 the situation, it's a difficult one to solve because you have to look at the economics of what it takes. If you want to keep drug prices low, and we've dropped drug prices in the generic space very, very low, the ones you see that are very, very expensive in general are not in the generic space. 90% of the drugs we take in the United States are generics, roughly.